Risk for fractures with centrally acting muscle relaxants: An analysis of a national medicare advantage claims database

Annals of Pharmacotherapy

Volumn 44, Issue 9, 2010, Pages 1369-1375

  Golden, Adam G ^a,b   Qianli, Ma ^c   Nair, Vinit ^c   Florez, Hermes J ^a,b,e   Roos, Bernard A ^a,b,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d Stein Gerontological Institute   (United States)

^e GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Benzodiazepines; Falls; Muscle relaxants

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; CARISOPRODOL; CENTRAL MUSCLE RELAXANT; CHLORDIAZEPOXIDE; CHLORZOXAZONE; CLONAZEPAM; CLORAZEPATE; CYCLOBENZAPRINE; DIAZEPAM; ESTAZOLAM; FLURAZEPAM; LORAZEPAM; METAXALONE; METHOCARBAMOL; OXAZEPAM; OXYBUTYNIN; QUAZEPAM; TEMAZEPAM; TRIAZOLAM;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIZZINESS; DRUG USE; FEMALE; FRACTURE; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HIP FRACTURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PELVIS FRACTURE; PRIORITY JOURNAL; RADIUS FRACTURE; RISK; RISK ASSESSMENT; SIDE EFFECT; SKULL FRACTURE; SOMNOLENCE; ULNA FRACTURE;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; BENZODIAZEPINES; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; FRACTURES, BONE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MEDICARE PART C; MUSCLE RELAXANTS, CENTRAL; RISK; UNITED STATES;

EID: 77956235631     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P210     Document Type: Article

References (45)

1. See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician 2008;78:365-70.
2. Fantl JA, Newman DK, Colling J, et al. Managing acute and chronic urinary incontinence. Clinical practice guideline. Quick reference guide for clinicians, no. 2, 1996 update. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Pub. No. 96-0686, January 1996.
3. Thüroff J, Abrams P, Anersson KE, et al. Guidelines on urinary incontinence. European Association of Urology, 2006. www.uroweb.org/fileadmin/ user-upload/Guidelines/16%20Urinary%20Incontinence.pdf (accessed 2009 Sept 30).
4. Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low-back pain. Cochrane Database Syst Rev 2003;(4):CD004252. DOI 10.1002/14651858.CD004252
5. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007; 147:505-14. (Pubitemid 351664521)
6. Kay GG, About-Donia MB, Messer WS, et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005;53:2195-201.
7. Scheife R, Takeda M. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther 2005;27:144-53.
8. Kamel NS, Gammack JK. Insomnia in the elderly: cause, approach, and treatment. Am J Med 2006;119:463-9.
9. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009;169:1952-60.
10. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol 2007; 62:1172-81. (Pubitemid 47599431)
11. Leipzig RM, Cummings RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999;47:30-9.
12. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fractures in white women. N Engl J Med 1995;332:767-73.
13. Schneeweiss S, Wang PS. Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information. J Am Geriatr Soc 2005;53:948-54.
14. Herings RM, Stricker BH, de Boer A, et al. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995;155:1801-7.
15. Pierfitte C, Macouillard G, Thicipe M, et al. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 2001;322:704-8.
16. Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly. Arch Intern Med 2004;164:1567-72.
17. Avidan AY, Fries BE, James ML, et al. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53:955-62.
18. Wagner AK, Ross-Degnan D, Gurwitz JH, et al. Effect of New York state regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med 2007;146:96-103. (Pubitemid 351640012)
19. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk of fractures in older women. Arch Intern Med 2003;163:949-57.
20. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003;163:2716-24.
21. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001;286:2823-9.
22. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc 2007;55:S373-82.
23. Winchell GA, King JD, Chavez-Eng CM, et al. Cyclobenzaprine pharmacokinetics, including the effects of age, gender, and hepatic insufficiency. J Clin Pharmacol 2002;42:61-9.
24. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997;157:1531-6.
25. Bulat T, Castle SC, Rutledge M, Quigley P. Clinical practice algorithms: medications management to reduce fall risk in the elderly - part 4, anticoagulants, anticonvulsants, anticholinergics/bladder relaxants, and antipsychotics. J Am Acad Nurse Pract 2008;20:181-90.
26. Dillon C, Paulose-Ram R, Hirsch R, Gu Q. Skeletal muscle relaxant use in the United States. Spine 2004;29:892-6.
27. Wysowski DK, Baum C, Ferguson WJ, Lundin F, Moh-Jee NQ, Hammerstrom T. Sedative hypotic drugs and the risk of hip fractures. J Clin Epidemiol 1996;49:111-3. (Pubitemid 26089557)
28. Sattin RW. Falls among older persons: a public health perspective. Annu Rev Publ Health 1992;13:489-508.
29. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9.
30. Food and Drug Administration. NDC codes. www.fda.gov/cder/ndc/database/ default.htm (accessed 2009 Mar 18).
31. Rochan PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007;167:676-83.
32. Rapoport M, Mamdani M, Shulman KI, Herrmann N, Rochan PA. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry 2005;20:749-53.
33. Rochan PA, Normand S-L, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008;168:1090-6.
34. Anderson RU, Mobley D, Blank B, et al. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. J Urol 1999;161:1809-12. (Pubitemid 29420737)
35. Versi E, Appell R, Mobley D, et al. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. Obstet Gynecol 2000;95:718-21.
36. Coutinho ESF, Fletcher A, Bloch KV, Rodrigues LC. Risk factors for falls with severe fracture in elderly people living in a middle-income country: a case control study. BMC Geriatr 2008;8:21. DOI 10.1186/1471-2318-8-21
37. French DD, Campbell R, Spehar A, Rubenstein LZ, Branch LG, Cunningham F. National outpatient medication profiling: medications associated with outpatient fractures in community-dwelling elderly veterans. Br J Clin Pharmacol 2006;63:238-44. (Pubitemid 46072111)
38. Bramness JG, Skurtveit S, Mørland J, Engeland A. The risk of traffic accidents after prescription of carisoprodol. Accid Anal Prev 2007;39:1050-5.
39. Hanlon JT, Boudreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2009;64A:492-8.
40. Lewiecki EM. Managing osteoporosis: challenges and strategies. Cleve Clin J Med 2009;76:457-66.
41. Wilkins CH, Birge SJ. Prevention of osteoporotic fractures in the elderly. Am J Med 2005;118:1190-5.
42. Foley KA, Foster SA, Meadows ES, Baser O, Long SR. Assessment of the clinical management of fragility fractures and implications for the new HEDIS osteoporosis measure. Med Care 2007;45:902-6.
43. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999;47:40-50. (Pubitemid 29044265)
44. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003;327:712-8.
45. Chen JS, Simpson JM, March LM, et al. Fracture risk assessment in frail older people using clinical risk factors. Age Ageing 2008;37:536-41.